Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gastric carcinoma. Our experience]

R Bianchi1, F Galasso, I Urban

  • 1Istituto di Chirurgia d'Urgenza, Università degli Studi di Torino.

Minerva Gastroenterologica E Dietologica
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metastatic hidradenocarcinoma papilliferum in chronic hidradenitis: an emblematic case and a narrative review.

Archives of dermatological research·2024
Same author

Investigating the Nature of Late-Time High-Energy GRB Emission Through Joint <i>Fermi /Swift</i> Observations.

The Astrophysical journal·2022
Same author

BAYESIAN ANALYSIS OF COSMIC RAY PROPAGATION: EVIDENCE AGAINST HOMOGENEOUS DIFFUSION.

The Astrophysical journal·2021
Same author

Blood glucose and epicardial adipose tissue at the hospital admission as possible predictors for COVID-19 severity.

Endocrine·2021
Same author

Solution of Heliospheric Propagation: Unveiling the Local Interstellar Spectra of Cosmic-ray Species.

The Astrophysical journal·2021
Same author

<i>Fermi</i> LARGE AREA TELESCOPE OBSERVATIONS OF BLAZAR 3C 279 OCCULTATIONS BY THE SUN.

The Astrophysical journal·2021

This study suggests anti-H2 drugs may delay gastric cancer diagnosis. Patients treated with these drugs showed advanced cancer stages and poorer outcomes, prompting further investigation into diagnostic delays.

Area of Science:

  • Gastroenterology
  • Oncology
  • Pharmacology

Background:

  • Gastric cancer diagnosis and treatment outcomes are critical in oncology.
  • Anti-H2 drugs are commonly used for gastrointestinal conditions.
  • Previous research has explored factors influencing gastric cancer prognosis.

Purpose of the Study:

  • To investigate the potential association between anti-H2 drug use and delayed diagnosis in gastric cancer patients.
  • To analyze the relationship between anti-H2 drug treatment and gastric cancer staging and survival.
  • To evaluate if anti-H2 drugs might mask or postpone the identification of gastric malignancy.

Main Methods:

  • Retrospective analysis of 66 gastric cancer cases diagnosed between 1985 and 1992.
  • Categorization of patients based on treatment received, including anti-H2 drug therapy.

Related Experiment Videos

  • Correlation of treatment history with tumor stage, grade, diagnostic procedures, and long-term survival.

    • Main Results:

    • Of 66 patients, 52 underwent surgery and 16 received medical treatment.
    • 67% of operated patients died within four years, irrespective of tumor stage or treatment.
    • Patients treated with anti-H2 drugs (27 cases) exhibited more undifferentiated tumors, with 88% in advanced stages (III/IV).
    • 81% of anti-H2 drug users had a history of gastric ulcer but underwent initial endoscopy late.

    Conclusions:

    • The findings raise concerns that anti-H2 drug therapy might delay the diagnosis of gastric cancer.
    • Patients receiving anti-H2 drugs presented with more advanced disease, suggesting a potential negative impact on prognosis.
    • Further prospective studies are warranted to confirm the hypothesis of diagnostic delay induced by anti-H2 drugs in gastric cancer.